Penumbra reported Q4 sales of $315.52 million, up 10.8% Y/Y, beating estimates of $311.55 million. U.S. thrombectomy sales jumped 27.3%, driving global growth of 15.4%. Next: Get access to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback